Essilor : Expiration of the Liquidity Contract
CHARENTON-LE-PONT, France -- January 31, 2013
Regulatory News :
Essilor (Paris:EI) announces the expiration as of January 24, 2013 of the
liquidity contract signed with CA Cheuvreux. The Company’s liquidity account
included the following cash and Company common shares at this date:
As a reminder, the Company’s liquidity account included the following means at
December 31, 2012:
The world’s leading ophthalmic optics company, Essilor designs, manufactures
and markets a wide range of lenses to improve and protect eyesight. Its
corporate mission is to enable everyone around the world to access lenses that
meet his or her unique vision requirements. To support this mission, the
Company allocates around €150 million to research and development every year,
in a commitment to continuously bring new, more effective products to market.
Essilor’s flagship brands are Varilux^®, Crizal^®, Definity^®, Xperio^®,
Optifog™ and Foster Grant^®. It also develops and markets equipment,
instruments and services for eyecare professionals.
Essilor reported consolidated revenue of €4.2 billion in 2011 and employs
around 48,700 people in some 100 countries. It operates 19 plants, a total of
390 prescription laboratories and edging facilities, as well as several
research and development centers around the world.
For more information, please visit www.essilor.com.
The Essilor share trades on the NYSE Euronext Paris market and is included in
the EuroStoxx 50 and CAC 40 indices. Codes and symbols: ISIN: FR FR0000121667;
Reuters: ESSI.PA; Bloomberg: EI:FP.
Investor Relations and Financial Communications
Phone: +33 (0)1 49 77 42 16
Press spacebar to pause and continue. Press esc to stop.